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Abstract 
Tumor growth is a complex process characterized by uncontrolled cell proliferation and invasion of neighboring tissues. The 
understanding of these phenomena is of vital importance to establish appropriate diagnosis and therapeutic strategy and starts 
with the evaluation of their complexity with suitable descriptors, such as those produced by scaling analysis. In the present 
work, scaling analysis is used for the extraction of dynamic parameters that characterize tumor growth processes in brain tumors. 
The emphasis in the analysis is on the assessment of general properties of tumor growth, such as the Family-Vicsek ansatz, 
which includes a great variety of ballistic growth models. Results indicate in a definitive way that gliomas strictly behave as it 
is proposed by the ansatz, while benign tumors behave quite differently. As a complementary view, complex visibility networks 
derived from the tumor interface support these results and its use is introduced as a possible descriptor in the understanding of 
tumor growth dynamics. 
Scaling analysis; multifractal systems; complex networks
1. Introduction 
Tumors exhibit a complex and irregular geometry 
due to the uneven spatial distribution of their cells. 
This irregular geometry appears during their growth 
processes, and it is apparent in a tumor interface with 
its host, on a tumor vascular network, and even on a 
tumor’s spatial diffusion through time. Fractal 
geometry provides a notion of dimension that 
characterizes these complex and irregular objects. In 
the case of brain tumors, medical imaging technology 
has been fundamental for the geometrical analysis and 
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quantification of tumor lesions. Magnetic resonance 
imaging techniques with standard contrast 
enhancement, dynamic contrast enhancement, and 
susceptibility weighting give detailed geometrical 
information with excellent spatial resolution and 
quality. When applied to the central nervous system, 
the precise characterization of tumor geometry, in all 
of its complexity, makes an important contribution to 
the understanding of brain tumor pathology. This 
precise geometric characterization leads to new 
methods for tumor segmentation and tissue 
classification in enhanced contrast MRI [1], tumor 
grading [2, 3], and therapy monitoring [3, 4]. 
Parameters extracted from the complex tumor growth 
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dynamics [6–10, 11, 12] can be used to validate tumor 
growth models [13-16] for therapy simulation and 
prognosis [17]. Also, brain tumor complexity and 
neural brain complexities can be considered to 
produce models that estimate neurological 
implications of tumor resection [18] and neurological 
disorders [19, 20] due to the presence of brain tumors. 
Fractal dimension has been used to characterize 
morphological irregularities in cancer pathologies and 
to assess their grade and malignancy [21,22]. It has 
been used to establish clear geometrical differences 
between normal, dysplastic, and neoplastic tissues 
[23]. In the case of brain tumors, fractal dimension, as 
box-counting or capacity dimension, has been used for 
tumor segmentation in brain images [1, 3, 24, 25], 
tumor grading [2, 3], and assessment of the effects of 
therapy [3, 4]. In these applications, magnetic 
resonance images with contrast enhancement [3], 
susceptibility-weighted MRI (which are known as 
SWI [2, 4]), and histological brain tumor specimens 
[26-29] have been evaluated. The magnetic resonance 
imaging modalities used in these studies have high 
spatial resolution and provide a proper rendering of 
tumor lesion features. Fractal dimension can also be 
extracted from the tumor interface after performing an 
image segmentation process. Several works [11, 12, 
30, 31] analyzed tumor interfaces extracted from 
contrast-enhanced magnetic resonance images and 
determined the fractal capacity dimension of the tumor 
interface. Summarizing, the set of fractal dimensions, 
each one associated to a feature of the tumor lesion, 
e.g., contrast agent intensity, image texture, 
vascularity, and tumor interface, supply an adequate 
description to characterize the transitions from normal 
to dysplastic to neoplastic tissue [23]. This description 
is of great help in diagnosis and therapy monitoring. 
Fractal capacity dimension is in general very easy to 
calculate by box-counting or sandbox algorithms, 
which makes it useful for its extended use in clinical 
applications and computer-aided diagnosis. However, 
fractal capacity dimension alone does not adequately 
describe multifractal systems [30, 32-34], so a more 
general approach to assess the complex behavior of 
cancer must be addressed using scaling analysis 
techniques [6-9, 11, 12, 30]. 
The sections in this article are organized as follows: 
first, the use of a scaling analysis approach to estimate 
growth parameters extracted from tumor interface 
dynamics and their relation to fractal dimensions 
stressing the pertinence of the Family-Vicsek ansatz 
[35] as a discriminator between malignant and benign 
tumors in brain. In second instance, some multifractal 
analysis techniques are discussed, e.g., a time-like 
series derived from the tumor interface’s rugosity and 
its associated complex network are analyzed, visibility 
networks [36, 37] are used to discriminate between 
malignant and benign tumors [10]. 
2. Methods 
2.1. Image analysis 
2.1.1. Image selection 
Images for high grade gliomas were extracted from 
different collections in The Cancer Imaging Archive 
[40, 41]; The Cancer Genome Atlas Low Grade 
Glioma (TCGA-LGG) data collection [42] and the 
Repository of Molecular Brain Neoplasia Data 
(REMBRANDT) [43] for astrocytomas and 
oligodendrogliomas of grades 2 and 3, and The Cancer 
Genome Atlas Glioblastoma Multiforme [TCGA-
GBM] collection [44] for glioblastoma multiforme. 
For benign brain tumors, local image datasets were 
used. Among these collections, T1-weighted images, 
either contrast enhanced or not, were selected and 
further reviewed, i.e., tumor lesions should be clearly 
identified as such and separated from anatomical 
structures, for image processing. 
2.1.2. Image processing and tumor interface 
extraction 
The selected images were subjected to the 
following processing scheme: 
Step 1: Selection on the slices that include 
observable tumor lesion. 
Step 2: If two MRI modalities are available, post 
and pre contrast T1-weighted MRI, the images are 
then registered using affine transformations, the One 
plus One Evolutionary method [45] as optimizer and 
the Mutual Information [46] as a metric, using the 
Mattes algorithm [47]. In the case of a single MRI 
modality, i.e., contrast enhanced T1-weighted, this 
step is skipped. 
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Step 3: Regions of interest or ROIs are selected 
slice by slice surrounding the tumor lesion. Digital 
levels obtained from these regions are classified 
according to the k-means algorithm [48]. To estimate 
the number of possible classes, a clustering method 
based on quantum mechanics proposed by Horn et al. 
[49] was used. The method assumes that the Parzen 
estimator [50] of the data points corresponds to the 
ground state of the Schrödinger equation and a 
potential energy can be obtained for that state. Applied 
to digital levels, the Parzen estimator is given by the 
convolution of the image histogram with the gaussian 
kernel, 
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The potential 𝑉 is in fact a better discriminant [49] 
of the cluster structure than the Parzen estimator, i.e., 
there are more minima in the potential function than 
maxima in the Parzen estimator, as a consequence, the  
selection  of a number of classes that correspond to the 
number of potential minima provides a secure starting 
point for the application of the k-means algorithm in 
the classification of the digital leves in the image. 
After the classification procedure performed by the k-
means algorithm is done, all classes that correspond to 
tumor activity, i.e., contrast enhanced voxels, are 
selected by inspection with no restriction of the 
number of classes involved and the image is 
segmented accordingly. Some examples of the 
proposed classification scheme are shown in figure 1. 
 
Fig.  1. Examples of results applying the proposed 
segmentation and classification scheme. On top, segmented images 
corresponding to glioblastoma multiforme (left) and acoustic 
schwannoma (right). Bottom, graphics representing the Parzen 
estimator and its associated Schrödinger potential for both cases. 
 
Step4: Determination of the tumor interface is 
performed by a method described elsewhere [12] and 
the results are reviewed slice by slice to exclude 
structures not related to the tumor interface.  
The general procedure is shown schematically in 
figure 2. 
 
 
Fig.  2. Schematic representation of the segmentation and 
classification procedure to obtain the tumor interface. In the case 
of a single modality acquisition, i.e., contrast enhanced T1-
weighted MRI, the first to steps are omitted. 
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2.2. The scaling analysis approach 
Besides fractal dimension, there are other ways to 
describe the fractal geometry of a system. Many other 
exponents can be derived from the observed power-
law behavior through scale transformations. Tumors 
are complex adaptive systems that can be 
characterized by dynamics similar to power-law 
behavior. The growth of tumors, in both resected and 
in vitro samples, has been characterized using a 
combination of fractal and scaling analysis techniques 
[6-9]. These studies have shown that tumor contours 
exhibit super-rough scaling dynamics described by the 
Family-Vicsek ansatz [35], which establishes that, for 
a balistic growth process, the interface width scales as 
[5], 
𝑊(𝐿, 𝑡)~𝐿𝛼𝑓 (
𝑡
𝐿𝑧
)          (3) 
where 𝐿, is the size of the system and 𝑓(𝑢) is a general 
function, which depends of the particular 
characteristics of the physical system, which satisfies 
𝑓(𝑢)~𝑢𝛽, if 𝑢 ≪ 1 and 𝑓(𝑢)~𝑐, a constant, if 𝑢 ≫ 1; 
𝛼, the roughness exponent, 𝛽, the growth exponent 
and 𝑧, the dynamic exponent are related by 𝑧 = 𝛼 𝛽⁄ . 
In these studies [6–9] it was demonstrated that this 
scaling behavior [35] applies at the local as well as the 
global level. As a consequence, the tumor interface can 
be also parameterized by a local roughness exponent, 
αloc, besides a global roughness exponent, α >1 [6-9].  
In three dimensions, the local roughness exponent 
relates the scale-averaged width of the interface 
between tumor and host to the scale of growth given 
by the area of a spherical cap, s, exhibiting a power-
law behavior [6-9] for small s: 
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with W given by [9], 
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where 〈𝑟𝑖〉𝑠 represents the average radius, measured 
from the tumor center, over an interface spherical cap 
of area s, and {∗}Σ  represents the average over all 
realizations (all possible spherical caps of area s) over 
the interface surface Σ. 
In order for the growing process to follow the 
Family-Vicsek ansatz [35], fractal dimension and local 
roughness exponent are related in a general way [5, 
35], i.e., their sum is equal to the embedding 
dimension of the shape, or Euclidean dimension, 𝑑𝐸, 
 
𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 𝑑𝐸           (6) 
Previous studies [38] performed on the tumor 
interface of contrast-enhanced MRI, using big [39] 
local and international databases, such as The Cancer 
Imaging Archive [40, 41] revealed that the condition 
given by equation (5) holds only for glioblastoma 
multiforme and high grade gliomas, 𝛼𝑙𝑜𝑐 = 0.89 ±
0.08, 𝑑𝐹 = 2.11 ± 0.08 with 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 3.00 ±
0.13 while in the case of meningiomas and other 
benign tumors, the result of 𝛼𝑙𝑜𝑐 = 0.76 ± 0.08, 𝑑𝐹 =
1.91 ± 0.06, with 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 2.67 ± 0.11 is 
obtained, stressing the fact that both types of tumors 
exhibit a very different dynamical growth behavior.  
Also it is possible to obtain the roughness exponent 
𝛼, which is related to the interface width, 𝑊, through 
the power-law behavior [5, 9, 35] and equation (3),  
 
    𝑊𝑠𝑎𝑡(𝑅)~𝑅
𝛼           (7) 
where 𝑅 is the mean radius of the tumor as a measure 
of its size, and it is assumed that for in vivo tumors, 
the saturation condition is attained, i.e., that the lateral 
correlation length for the interface fluctuations is 
comparable or larger than the size of the system [5, 
35]. The results previously obtained [38] for the 
exponent 𝛼 were 1.002 for glioblastoma multiforme, 
1.262 for metastasis, 0.963 for meningiomas and 
0.889 for acoustic schawnnomas. Glioblastomas and 
metastases exhibit an exponent 𝛼 > 1, which 
corresponds to a super-rough dynamics for the tumor 
growth process, denoting the highly invasive character 
that’s typical of malignant neoplastic tissue 
characterized by high proliferation and diffusion to the 
tumor interface, in contrast to the case of benign 
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tumors which obey to a growth dynamics of a bulk 
proliferative process with no diffusion to the tumor 
interface. 
2.3. Complex network analysis 
Tumor interface growth exhibit multifractal 
behavior that can not be characterized solely by 
capacity fractal dimension. More information about 
the complex dynamics at the tumor interface can be 
obtained by time series analysis. Brú et al. [51] have 
established a link between the evolution of complex 
networks and the dynamical processes that produce 
rough and fractal-like interfaces. The degree of the 
nodes in these networks change through time as the 
interface evolves. The application of this network 
methodology enables the uncovering of so-called 
“scale-free” temporal and geometric features that 
remain invariant as the interface grows. This 
invariance is detected in the degree distribution of the 
complex network derived from the interface. This 
approach could possibly be used to understand tumor 
interface dynamics.  
In particular, visibility graphs defined by Lacasa et 
al. [52, 53] obtained from the tumor interface points 
can be used to capture the geometrical correlations that 
exist among the discrete points that this interface. In 
general, tumor interface data points are scattered in a 
two-dimensional array in a very complex manner, as 
shown in figure 3, which makes streamly difficult the 
evaluation of the visibility graph in a general way.  
 
 
Fig.  3. Example of the complexity of the two-dimensional 
array of tumor interface data points for a glioblastoma multiforme. 
On the left, the angular coordinates for each data point and on the 
right, the complex fluctuations of the radius. 
One simplifying assumption is to obtain one-
dimensional spatially ordered series derived from 
geometrical adjacent points over the tumor interface. 
The simplest approach is to consider spatially ordered 
series coming from interface points located on the 
same image slice, which means that these points are 
ordered according to the angle ϕ, and spatial 
correlation could be revealed from the ordered series 
analysis, as shown in figure 4. 
The visibility graph is therefore obtained as 
discussed elsewhere [10, 36, 37] and the associated 
connectivity or degree distribution is determined for 
the complete set of slices that comprise the tumor 
interface. Also, as these ordered series exhibit periodic 
boundary conditions with respect to the ordering 
parameter, the connectivity for every single node of 
the visibility graph can be obtained appropriately. 
 
 
Fig.  4. Extraction of one-dimensional spatially ordered series. 
(a) Slice localization within the tumor interface, (b) Sampling of 
interface points 𝑅(𝜙) and (c) spatially ordered series. 
 
For a network, the connectivity can be established 
by the simple counting of edges for each node, this 
count being defined as its degree. The result of this 
computation for all the nodes in the network is a 
distribution of degrees. If one considers this 
distribution as a probability distribution, 𝑃(𝑘), it 
represents how a particular node, selected randomly, 
is connected to exactly k nodes. The presence of a 
power law behavior usually denotes a scale-free 
character for the visibility graph,  
 
       𝑃(𝑘)~𝑘𝛾           (8) 
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It is possibly expected that the exponent 𝛾 will 
differ significantly according to the tumor interface 
irregularity. 
3. Results and discussion 
A total of 295 tumor interfaces were analyzed, 
discriminated as follows, 130 benign tumors including 
meningiomas and acoustic schwannomas, 55 Grade II 
an Grade III astrocytomas and oligodendrogliomas 
[42,43], and 110 glioblastoma multiforme Grade IV 
tumors [44]. To extract the tumor interface, all image 
data sets were segmented by the k-means algorithm 
using as many classes as predicted by the Schrödinger 
potential [49], 𝑽, given by equation (2). In the majority 
of the cases, the number of classes were between 6 and 
8, and among them up to 4 classes were related to 
tumor activity. Average geometrical properties of the 
tumor interface are summarized in Table 1. 
 
Table 1. Average geometrical properties of tumor interface. 
〈𝑾〉, average interface width, 〈𝑹〉, average radius, and 〈𝑵〉, average 
number of  tumor interface points. 
 
Tumor group 〈𝑾〉 (mm) 〈𝑹〉 (mm) 〈𝑵〉 
Benign tumors 2.47 ± 0.84 11.92 ± 2.03 7691 
Grade II and III 
gliomas 
4.35 ± 1.73 15.57 ± 4.34 10632 
Glioblastoma 
multiforme 
4.90 ± 1.49 19.08 ± 4.14 14786 
 
Analysis of Table 1 immediately reveals a dramatic 
change in the average interface width comparing 
benign tumors to malignant ones, possibly due to an 
increase of the interface roughness and fractality, 
associated to proliferative-invasive processes that 
characterize cancerous tumors. 
3.1. Scaling analysis results 
The results obtained from the scaling analysis are 
somewhat scattered in the 𝜶𝒍𝒐𝒄 − 𝒅𝑭 parameter space 
as can be seen in figure 5, in which it is evident that 
the data points are clustered about two well defined 
classes corresponding mainly to benign and malignant 
tumors respectively.  
 
 
Fig.  5. Left, scatter plot of the results in the 𝛼𝑙𝑜𝑐 − 𝑑𝐹 
parameter space; green symbols correspond to benign tumors, red 
to glioblastoma multiforme and blue to grade II and Grade III 
gliomas; center, Parzen estimator and on the right, the associated 
Schrödinger potential. 
 
Also, from figure 5, contour plots for the Parzen 
estimator and its associated Schrödinger potential 
suggest the possibility of a greater number of classes, 
i.e., through the number of potential minima [49], 
corresponding each one to different tumor grades or 
histologies. 
The evaluation of the scaling analysis parameters 
yielded for glioblastoma multiforme, 𝛼𝑙𝑜𝑐 = 0.88 ±
0.06, 𝑑𝐹 = 2.17 ± 0.07,  with 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 3.05 ±
0.10, for Grade II and III gliomas, 𝛼𝑙𝑜𝑐 = 0.89 ±
0.07, 𝑑𝐹 = 2.10 ± 0.11, and 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 2.99 ±
0.13, and for benign tumors, 𝛼𝑙𝑜𝑐 = 0.77 ± 0.07, 
𝑑𝐹 = 2.02 ± 0.09, and 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 2.79 ± 0.13, 
which are in agreement of previous results [38]. The 
difference in scaling parameters between gliomas with 
different tumor gradings is not significant, not being 
this the case when compared to benign tumors. This 
fact can be supported further if a k-means 
classification procedure is performed over the 𝛼𝑙𝑜𝑐 −
𝑑𝐹 parameter space (see figure 5) assuming only two 
classes, malignant and benign tumors. The 
classification yielded for the malignant tumors, i.e., 
gliomas, independently of grading, 𝛼𝑙𝑜𝑐 = 0.89 ±
0.06, 𝑑𝐹 = 2.18 ± 0.07, and 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 3.07 ±
0.09, and for benign tumors, 𝛼𝑙𝑜𝑐 = 0.77 ± 0.08, 
𝑑𝐹 = 2.00 ± 0.06, and 𝛼𝑙𝑜𝑐 + 𝑑𝐹 = 2.77 ± 0.10. 
Evaluating this classification scheme as a predictive 
method for diagnosis it has a sensitivity of 0.8364, a 
specificity of 0.8846, an accuracy of 0.8576 and a 
precision of 0.9020. The method could be improved 
noticeable if high resolution images can be afforded 
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by, for example, reducing slice thickness and in plane 
resolution. 
It is important to notice that the variations in the 
values for the local roughness exponent, 𝛼𝑙𝑜𝑐, and the 
fractal dimension, 𝑑𝐹, determines what proliferative-
invasive process describing the dynamics of tumor 
growth is present. The results obtained by scaling 
analysis are in agreement to what is to be expected for 
the geometrical parameters shown in Table 1. As 
previously reported [38], high grade gliomas and 
glioblastomas definitely exhibit a balistic growth 
model, characterized by the ansatz of Family-Vicsek 
[35], equation (3), while in the case of benign tumors 
a different grrowth model have to be considered since 
equation (6) does not apply. 
Furthermore, and following equations (3) and (7), 
the global roughness exponent, 𝛼, for high grade 
gliomas and glioblastomas is, respectively, 1.17 and 
1.11, which means that the growth process 
corresponds to a super-rough dynamics compared to a 
rather smooth growth process for benign tumors with 
𝛼 = 0.87. These results are shown in figure 6. 
 
 
Fig.  6. Dependence of the saturation value of the interface 
width with tumor size. Lines represent, black continuous, data 
trend; red segmented, data confidence interval and black dotted, 
data prediction interval. Exponents are determined assuming 
equation (7). (a) Benign tumors, α = 0.87, (b) Grade II and III 
Gliomas,  α = 1.17 and (c) glioblastoma multiforme, α = 1.11. 
3.2. Complex network analysis results 
One dimensional spatially ordered series were 
obtained by the procedure shown in figure 4. Due to 
restrictions in the size of the series, i.e., some lesions 
were not big enough for a reliable calculation of the 
degree distribution, only a subset of the total number 
of tumor interfaces were considered, 102 benign 
tumors, 50 high grade gliomas and 101 glioblastomas. 
Some examples of the calculated degree distribution, 
for a meningioma and a Grade III astrocytoma, are 
shown in figure 7. As can be seen in the figure, 
individual degree distributions are subjected to 
fluctuations that depend on the number of points at the 
tumor interface, so an individual evaluation of the 
power law exponents depends on the size of the tumor 
lesion and differences between tumor groups are 
somewhat diminished. This fact limits the evaluation 
of the exponent only to large tumor lesions, such as 
glioblastomas and some high grade gliomas, excluding 
the majority of benign tumors, according to table 1. 
In order to establish a characteristic degree 
distribution for a tumor group, all the points belonging 
to the tumor interfaces within the group are considered 
as nodes of a visibility graph that will be representative 
of the whole group, under the assumption that tumor 
interface fluctuations are similar for tumors belonging 
to the same group. 
 
 
Fig.  7. Examples of the degree distribution 𝑃(𝑘)  and 𝑘 series 
for a meningioma (top) and a Grade III astrocytoma (bottom). 
 
Assuming only three groups, i.e., benign tumors, 
Grade II and III gliomas and glioblastomas, the group 
degree distributions are shown in figure 8, all of them 
exhibit two regions for which a power law behavior 
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can be extracted, the first one in the range of 3 < 𝑘 ≤
10 and the second one for 10 < 𝑘 ≤ 20, just before 
the onset of the cut off in the degre distribution due to 
the finite size of the spatially ordered series. 
 
 
Fig.  8. Group degree distributions for (a) Benign tumors, (b) 
Grade II and Grade III gliomas and (c) glioblastoma multiforme. 
Red lines indicate the power law fit for the first region. (d) 
Exponents for the power law behaviors for each tumor type. 
 
Results reveal significant differences between the 
tumor groups in the exponent for the first power law 
region, γ1, obtaining −1.48 ± 0.06, for benign 
tumors, −2.02 ± 0.10, for Grade II and III gliomas 
and −2.32 ± 0.05, for glioblastomas. For the second 
region the obtained exponents, γ2, are −0.63 ± 0.03, 
for benign tumors, −0.95 ± 0.06, for Grade II and III 
gliomas and −1.12 ± 0.07, for glioblastomas. 
Comparing the results obtained for γ1 with those 
published by Brú et al. [10], where different growth 
models that obey the Family-Vicsek ansatz are 
analyzed by visibility graphs, there is some 
correspondence of the Edwards-Wilkinson [51] and 
Kardar-Parisi-Zhang [52] models, which exhibit γ in 
the range −2.10 to −2.07 [10], with the result 
obtained for Grade II and III gliomas, and of the 
Random Deposition with Surface Relaxation [53] and 
Eden [54] models, with γ in the range −2.46 to −2.25, 
with the result for glioblastoma multiforme. In the case 
of benign tumors the comparison is not possible since, 
as it was previously disscused, its growth dynamics 
does not correspond to a balistic deposition growth 
model and therefore, it is beyond the analysis of 
reference [10], but nevertheless, this fact adds up to 
assess a different growth model for this group. The 
meaning of the second exponent, γ2, is still unclear 
since it is affected by the cut off in the degree 
distribution due to the size of the spatially ordered 
series, which is rather small, i.e., the maximum size for 
the tumor interfaces analized in this work is of the 
order of 2000. Nevertheless, exponents for high grade 
gliomas and glioblastomas are more negative than 
those for benign tumors, a result that is consistent with 
results for the first exponent γ1, and those coming 
from scaling analysis and Table 1. One possible 
interpretation is that in malignant tumors, points are 
dispersed on a wide hiper rough interface, and it is 
expected that the majority of nodes in the visibility 
graph are located in deep valleys and as a consecuence 
the degree distribution falls off more rapidly with k. In 
the case of benign tumors since they exhibit a smooth 
interface and its width is smaller than for malignant 
ones, as shown in Table 1,  the number of connections 
for each node will not differ in much depending on its 
location on the interface and therefore its degree 
distribution will fall off more slowly.  
It has to be remarked that the spatially ordered 
series considered in this work and in reference [10] are 
considered “flat”, in the sense that the horizon is 
always visible no matter the length of the series. Under 
actual conditions, the tumor interface is a closed 
surface and therefore points at the interface are hidden 
by the bulk volume of the tumor. As a consecuence, 
the degree distributions, P(k), are limited to a certain 
number of neighbours what implies an smaller cut off 
connectivity for the visibility graph, and possibly 
characteristic exponents may vary, so the previous 
correspondence with growth models should be taken 
within the context of reference [10].  
Visibility graphs and corresponding degree 
distributions were calculated for the different tumor 
types assuming a closed tumor interface, and the 
degree distributions are shown in figure 9, comparing 
benign tumors and glioblastoma multiforme.  
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Fig. 9. Degree distributions for visibility graphs considering 
“curved” spatially ordered series. (a) Benign tumors and (b) 
glioblastoma multiforme. 
 
Since a fast fall off in the connectivity is expected 
only one exponent 𝛾 was considered. The obtained 
exponents were −1.67 for benign tumors and −1.99 
for glioblastoma multiforme, showing the same 
tendency as previous results. 
4. Conclusions 
It is presented a general methodology to extract 
tumor interfaces from contrast enhanced MRI by a 
classification scheme that includes the assessment of 
the number of classes given by the number of minima 
of a quantum mechanically based Schrödinger 
potential for its use in a k-means classification 
algorithm. The extracted interfaces, belonging to 
different tumor groups including meningiomas, 
acoustic schwannomas, Grade II and III astrocytomas 
and oligodendrogliomas, and glioblastomas, were 
evaluated in relation to its geometrical properties and 
dynamics. It was demonstrated that for gliomas, 
independently ot its grade, the tumor growth dynamics 
completely adjust to a growth process that obey the 
Family-Vicsek ansatz, while for benign tumors, a 
different growth model has to be proposed. The use of 
complex visibility networks add some support to this 
result in a consistent manner, but limited by the tumor 
interface size. This will require some improvements in 
image acquisition in relation to spatial resolution. 
Further work is necessary to exploit the full capacity 
of complex networks analysis in extracting the 
dynamic characteristics of tumor growth, a task that 
will be acomplish in the near future. 
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